tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks price target raised to $33 from $31 at JPMorgan
The FlyZymeworks price target raised to $33 from $31 at JPMorgan
5d ago
ZYME
Zymeworks price target raised to $38 from $37 at Citi
PremiumThe Fly
Zymeworks price target raised to $38 from $37 at Citi
13d ago
ZYME
Zymeworks price target raised to $55 from $51 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $55 from $51 at H.C. Wainwright
13d ago
ZYME
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
PremiumCompany Announcements
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
14d ago
ZYME
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
PremiumCompany Announcements
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
14d ago
ZYME
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
PremiumThe FlyBeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
14d ago
ONC
JAZZ
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
Premium
The Fly
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
14d ago
ONC
JAZZ
Zymeworks Steps Up Investor Outreach with September Conference Lineup
Premium
Company Announcements
Zymeworks Steps Up Investor Outreach with September Conference Lineup
28d ago
ZYME
Zymeworks price target raised to $44 from $40 at B. Riley
PremiumThe Fly
Zymeworks price target raised to $44 from $40 at B. Riley
29d ago
ZYME
Citi adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
PremiumThe Fly
Citi adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
29d ago
ZYME
Zymeworks price target raised to $32 from $31 at Truist
PremiumThe Fly
Zymeworks price target raised to $32 from $31 at Truist
1M ago
ZYME
Zymeworks price target lowered to $46 from $47 at Stifel
PremiumThe Fly
Zymeworks price target lowered to $46 from $47 at Stifel
1M ago
ZYME
Zymeworks price target raised to $40 from $37 at Wells Fargo
PremiumThe FlyZymeworks price target raised to $40 from $37 at Wells Fargo
1M ago
ZYME
Zymeworks reports Q2 EPS (62c), consensus (55c)
Premium
The Fly
Zymeworks reports Q2 EPS (62c), consensus (55c)
1M ago
ZYME
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
Premium
Company Announcements
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
1M ago
8K
ZYME
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
1M ago
JNJ
JAZZ
Zymeworks management to meet with B. Riley
PremiumThe Fly
Zymeworks management to meet with B. Riley
2M ago
ZYME
Zymeworks price target raised to $31 from $28 at Truist
PremiumThe Fly
Zymeworks price target raised to $31 from $28 at Truist
2M ago
ZYME
Zymeworks price target raised to $37 from $34 at Wells Fargo
PremiumThe Fly
Zymeworks price target raised to $37 from $34 at Wells Fargo
2M ago
ZYME
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
PremiumRatingsZymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
2M ago
ZYME
Zymeworks price target raised to $37 from $35 at Citi
Premium
The Fly
Zymeworks price target raised to $37 from $35 at Citi
2M ago
TBPH
ZYME
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
Premium
Ratings
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >